The Daily Populous Monday February 9th, 2026 evening edition
Authored by ecancer.org and submitted by gudfrid

Professor Kwang-Hyun Cho’s research team has recently been highlighted for their work on developing an original technology for cancer reversal treatment that does not kill cancer cells but only changes their characteristics to reverse them to a state similar to normal cells.

This time, they have succeeded in revealing for the first time that a molecular switch that can induce cancer reversal at the moment when normal cells change into cancer cells is hidden in the genetic network.

KAIST (President Kwang-Hyung Lee) announced on the 5th of February that Professor Kwang-Hyun Cho's research team of the Department of Bio and Brain Engineering has succeeded in developing a fundamental technology to capture the critical transition phenomenon at the moment when normal cells change into cancer cells and analyse it to discover a molecular switch that can revert cancer cells back into normal cells.

A critical transition is a phenomenon in which a sudden change in state occurs at a specific point in time, like water changing into steam at 100℃.

This critical transition phenomenon also occurs in the process in which normal cells change into cancer cells at a specific point in time due to the accumulation of genetic and epigenetic changes.

The research team discovered that normal cells can enter an unstable critical transition state where normal cells and cancer cells coexist just before they change into cancer cells during tumorigenesis, the production or development of tumours, and analysed this critical transition state using a systems biology method to develop a cancer reversal molecular switch identification technology that can reverse the cancerization process.

They then applied this to colon cancer cells and confirmed through molecular cell experiments that cancer cells can recover the characteristics of normal cells.

This is an original technology that automatically infers a computer model of the genetic network that controls the critical transition of cancer development from single-cell RNA sequencing data, and systematically finds molecular switches for cancer reversion by simulation analysis.

It is expected that this technology will be applied to the development of reversion therapies for other cancers in the future.

Professor Kwang-Hyun Cho said, "We have discovered a molecular switch that can revert the fate of cancer cells back to a normal state by capturing the moment of critical transition right before normal cells are changed into an irreversible cancerous state."

< Figure 1. Overall conceptual framework of the technology that automatically constructs a molecular regulatory network from single-cell RNA sequencing data of colon cancer cells to discover molecular switches for cancer reversion through computer simulation analysis.

Professor Kwang-Hyun Cho's research team established a fundamental technology for automatic construction of a computer model of a core gene network by analysing the entire process of tumorigenesis of colon cells turning into cancer cells, and developed an original technology for discovering the molecular switches that can induce cancer cell reversal through attractor landscape analysis.>

He continued, "In particular, this study has revealed in detail, at the genetic network level, what changes occur within cells behind the process of cancer development, which has been considered a mystery until now." He emphasised, "This is the first study to reveal that an important clue that can revert the fate of tumorigenesis is hidden at this very critical moment of change."

< Figure 2. Identification of tumour transition state using single-cell RNA sequencing data from colorectal cancer.

Using single-cell RNA sequencing data from colorectal cancer patient-derived organoids for normal and cancerous tissues, a critical transition was identified in which normal and cancerous cells coexist and instability increases (a-d).

The critical transition was confirmed to show intermediate levels of major phenotypic features related to cancer or normal tissues that are indicative of the states between the normal and cancerous cells (e).>

The results of this study, conducted by KAIST Dr. Dongkwan Shin (currently at the National Cancer Centre), Dr. Jeong-Ryeol Gong, and doctoral student Seoyoon D.

Jeong jointly with a research team at Seoul National University that provided the organoids (in vitro cultured tissues) from colon cancer patient, were published as an online paper in the international journal ‘Advanced Science’ published by Wiley on January 22nd.

< Figure 3. Reconstruction of a dynamic network model for the transition state of colorectal cancer.

A new technology was established to build a gene network computer model that can simulate the dynamic changes between genes by integrating single-cell RNA sequencing data and existing experimental results on gene-to-gene interactions in the critical transition of cancer.

(a). Using this technology, a gene network computer model for the critical transition of colorectal cancer was constructed, and the distribution of attractors representing normal and cancer cell phenotypes was investigated through attractor landscape analysis (b-e). >

This study was conducted with the support of the National Research Foundation of Korea under the Ministry of Science and ICT through the Mid-Career Researcher Programme and Basic Research Laboratory Programme and the Disease-Centred Translational Research Project of the Korea Health Industry Development Institute (KHIDI) of the Ministry of Health and Welfare.

< Figure 4. Quantification of attractor landscapes and discovery of transcription factors for cancer reversibility through perturbation simulation analysis.

A methodology for implementing discontinuous attractor landscapes continuously from a computer model of gene networks and quantifying them as cancer scores was introduced (a), and attractor landscapes for the critical transition of colorectal cancer were secured (b-d).

By tracking the change patterns of normal and cancer cell attractors through perturbation simulation analysis for each gene, the optimal combination of transcription factors for cancer reversion was discovered (e-h).

This was confirmed in various parameter combinations as well (i).>

< Figure 5. Identification and experimental validation of the optimal target gene for cancer reversion.

Among the common target genes of the discovered transcription factor combinations, we identified cancer reversing molecular switches that are predicted to suppress cancer cell proliferation and restore the characteristics of normal colon cells (a-d).

When inhibitors for the molecular switches were treated to organoids derived from colon cancer patients, it was confirmed that cancer cell proliferation was suppressed and the expression of key genes related to cancer development was inhibited (e-h), and a group of genes related to normal colon epithelium was activated and transformed into a state similar to normal colon cells (i-j).>

< Figure 6. Schematic diagram of the research results.

Professor Kwang-Hyun Cho's research team developed an original technology to systematically discover key molecular switches that can induce reversion of colon cancer cells through a systems biology approach using an attractor landscape analysis of a genetic network model for the critical transition at the moment of transformation from normal cells to cancer cells, and verified the reversing effect of actual colon cancer through cellular experiments.>

Source: The Korea Advanced Institute of Science and Technology (KAIST)

YourStudyBuddy on February 9th, 2026 at 13:46 UTC »

Sensationalized headlines like this are partially to blame for why the public has such a distrust of the medical community.

They neglect to specify what types of cancer this was shown in. Thousands of cancers exist, it isn’t a single disease where a single cure can be discovered. They each stem from different organs, tissues, etc, and they each respond to various treatments differently

Stating they reverse cancers cells back to normal without specifying what types of cancer gives the illusion that it is a single disease process and that a single “cure” can be found.

When that doesn’t pan out the public is left thinking it’s because scientists are hiding a cure. In reality, this was shown in a lab, not in a patient, and not for all cancers that exist. There is a LOT of work left to translate results in a lab to results in a human.

PlebiconValley on February 9th, 2026 at 12:33 UTC »

we'll see this again in 5 years on uplifting news... that it's made incremental process and is now 50 years away from implementation

luismt2 on February 9th, 2026 at 12:31 UTC »

Headlines always oversell, but reversing cancer cell behavior is still a big deal at the molecular level. The hard part is translating it safely to humans.